News
Reframing AUD as treatable may reduce stigma
- Author:
- Andrew D. Bowser
The opioid and COVID-19 crises grab attention, but alcohol use disorder is on the rise, Dr. George F. Koob said.
News
Anti-NMDAR encephalitis or primary psychiatric disorder?
- Author:
- Andrew D. Bowser
Once anti-NMDA receptor encephalitis is identified, most patients will benefit from immunotherapy and tumor removal, though recovery may take...
News
COVID-19: Telemedicine boosting access but is not a panacea
- Author:
- Andrew D. Bowser
Surging virtual visits are setting a precedent during the pandemic, but the future of telepsychiatry remains to be written, experts said.
News
COVID-19: Psychiatrists ‘more than a match’ for crisis moment
- Author:
- Andrew D. Bowser
Physicians can step up by fighting misinformation, holding leaders accountable, and tackling inequities, Dr. Patrice A. Harris said.
News
Get triage plans in place before COVID-19 surge hits, critical care experts say
- Author:
- Andrew D. Bowser
Decisions can place enormous ethical burdens on hospitals, health systems, and society, but planning for the worst may help optimize resource...
News
Want to keep cancer patients and providers safe during the pandemic? Here’s how
- Author:
- Andrew D. Bowser
Prescreening, telemedicine, and limited interventions top the list of best practices for patients, while PPE, telecommuting, and wellness/stress...
News
Breast-conserving surgery deemed okay in high-risk hereditary breast cancers
- Author:
- Andrew D. Bowser
The presence of a germline BRCA1/2 mutation shouldn’t preclude breast-conserving therapy as long as the patient is otherwise eligible, new...
News
Remdesivir tops list of promising COVID-19 treatments in review of nearly 300 trials
- Author:
- Andrew D. Bowser
Hydroxychloroquine data have “major limitations,” and corticosteroids are not recommended for supportive care.
News
Cancer prevalence among COVID-19 patients may be higher than previously reported
- Author:
- Andrew D. Bowser
A meta-analysis suggests the cancer prevalence among COVID-19 patients is 2%, not 1% as previously reported.
News
No benefit to trastuzumab after progression in HER2-positive gastric, GEJ cancers
- Author:
- Andrew D. Bowser
There was no significant difference in progression-free or overall survival between patients who received...
News
Stronger links forged between RA and asthma, COPD
- Author:
- Andrew D. Bowser
Findings from the first-ever prospective study to evaluate asthma and COPD as risk factors for RA suggest providers should lower bar for...
News
Real-world shortages not addressed in new COVID-19 guidance
- Author:
- Andrew D. Bowser
WHO provides up-to-date guidance on COVID-19 treatment, but real-world ingenuity will be needed to tackle thorny issues surrounding this disease...
News
TAVR device orientation may reduce coronary overlap
- Author:
- Andrew D. Bowser
Positioning the Evolut THV at a certain way at deployment led to an improvement in commissural alignment and a significant reduction in coronary...
News
High CV event risk seen in SLE patients with ACC/AHA-defined hypertension
- Author:
- Andrew D. Bowser
“It seems reasonable that clinicians should not rely on CV risk calculators in SLE and commence treatment as soon as possible in cases of...
News
Some infected patients could show COVID-19 symptoms after quarantine
- Author:
- Andrew D. Bowser
Longer quarantine could be considered in highest-risk scenarios, but benefits must be weighed against costs to public health and the quarantined...